Details

Autor(en) / Beteiligte

• Elimian, K. O.
• Ochu, C. L.
• Ilori, E.
• Oladejo, J.
• Igumbor, E.
• Steinhardt, L.
• Wagai, J.
• Arinze, C.
• Ukponu, W.
• Obiekea, C.
• Aderinola, O.
• Crawford, E.
• Olayinka, A.
• Dan-Nwafor, C.
• Okwor, T.
• Disu, Y.
• Yinka-Ogunleye, A.
• Kanu, N. E.
• Olawepo, O. A.
• Aruna, O.
• Michael, C. A.
• Dunkwu, L.
• Ipadeola, O.
• Naidoo, D.
• Umeokonkwo, C. D.
• Matthias, A.
• Okunromade, O.
• Badaru, S.
• Jinadu, A.
• Ogunbode, O.
• Egwuenu, A.
• Jafiya, A.
• Dalhat, M.
• Saleh, F.
• Ebhodaghe, G. B.
• Ahumibe, A.
• Yashe, R. U.
• Atteh, R.
• Nwachukwu, W. E.
• Ezeokafor, C.
• Olaleye, D.
• Habib, Z.
• Abdus-Salam, I.
• Pembi, E.
• John, D.
• Okhuarobo, U. J.
• Assad, H.
• Gandi, Y.
• Muhammad, B.
• Nwagwogu, C.
• Nwadiuto, I.
• Sulaiman, K.
• Iwuji, I.
• Okeji, A.
• Thliza, S.
• Fagbemi, S.
• Usman, R.
• Mohammed, A. A.
• Adeola-Musa, O.
• Ishaka, M.
• Aketemo, U.
• Kamaldeen, K.
• Obagha, C. E.
• Akinyode, A. O.
• Nguku, P.
• Mba, N.
• Ihekweazu, C.

Titel

Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020

Ist Teil von

• Epidemiology and infection, 2020-01, Vol.148, p.e208-e208, Article e208

Ort / Verlag

Cambridge, UK: Cambridge University Press

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• The objective of this study was to describe the epidemiology of COVID-19 in Nigeria with a view of generating evidence to enhance planning and response strategies. A national surveillance dataset between 27 February and 6 June 2020 was retrospectively analysed, with confirmatory testing for COVID-19 done by real-time polymerase chain reaction (RT-PCR). The primary outcomes were cumulative incidence (CI) and case fatality (CF). A total of 40 926 persons (67% of total 60 839) had complete records of RT-PCR test across 35 states and the Federal Capital Territory, 12 289 (30.0%) of whom were confirmed COVID-19 cases. Of those confirmed cases, 3467 (28.2%) had complete records of clinical outcome (alive or dead), 342 (9.9%) of which died. The overall CI and CF were 5.6 per 100 000 population and 2.8%, respectively. The highest proportion of COVID-19 cases and deaths were recorded in persons aged 31–40 years (25.5%) and 61–70 years (26.6%), respectively; and males accounted for a higher proportion of confirmed cases (65.8%) and deaths (79.0%). Sixty-six per cent of confirmed COVID-19 cases were asymptomatic at diagnosis. In conclusion, this paper has provided an insight into the early epidemiology of COVID-19 in Nigeria, which could be useful for contextualising public health planning.